Back to Search Start Over

Human rotavirus vaccine (RIX4414) efficacy in the first two years of life

Authors :
Yanping Li
Xue-Yan Liao
Htay Htay Han
Junhui Tao
Ivy Luan
Haiwen Tang
Rong-cheng Li
Teng Huang
Naveen Karkada
Yi Nong
Dong Luo
Guoai Si
Zhaojun Mo
Botao Fu
Niraj Rathi
Source :
Human Vaccines & Immunotherapeutics
Publication Year :
2013
Publisher :
Informa UK Limited, 2013.

Abstract

Rotaviruses (RV) are a major cause of severe gastroenteritis (GE) in children aged 10%. The number of unsolicited symptoms and SAEs reported was similar between both groups. Thirteen deaths (RIX4414 = 6; placebo = 7) occurred during the study. All SAEs and deaths in the RIX4414 group were considered unrelated to vaccination. Two oral doses of RIX4414 vaccine provided a substantial level of protection against severe RVGE in Chinese children during the first two years of life.

Details

ISSN :
2164554X and 21645515
Volume :
10
Database :
OpenAIRE
Journal :
Human Vaccines & Immunotherapeutics
Accession number :
edsair.doi.dedup.....962ec261dd4cf7a87db173552ae052b2
Full Text :
https://doi.org/10.4161/hv.26319